Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Pancreatic Neoplasms 42Neoplasms 17Neoplasm Metastasis 15Carcinoma, Non-Small-Cell Lung 14Breast Neoplasms 14Ovarian Neoplasms 11Triple Negative Breast Neoplasms 6Stomach Neoplasms 6Lung Neoplasms 6Melanoma 5Fallopian Tube Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Peritoneal Neoplasms 4Lymphoma, Non-Hodgkin 4Hodgkin Disease 4Carcinoma, Pancreatic Ductal 4Adenocarcinoma 4Recurrence 3Rectal Neoplasms 3Prostatic Neoplasms 3Lymphoma 3Head and Neck Neoplasms 3Gallbladder Neoplasms 3Endometrial Neoplasms 3Colorectal Neoplasms 3Urinary Bladder Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 2Small Cell Lung Carcinoma 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Lymphoma, B-Cell 2

Interventions

Fulvestrant 4palbociclib 3Letrozole 3Paclitaxel 2sonidegib 1ribociclib 1irinotecan sucrosofate 1elacestrant 1XMT-1522 1Vorinostat 1Sirolimus 1Ritonavir 1Population Groups 1Itraconazole 1Immunotherapy, Adoptive 1Histone Deacetylase Inhibitors 1FCN-437c 1Docetaxel 1Decitabine 1Dasatinib 1Combined Modality Therapy 1Capecitabine 1CYH33 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Advanced Breast Cancer × Albumin-Bound Paclitaxel × Clear all
NCT05274893 2022-03-11

A Pharmacokinetic Comparison Study of SYHX2011 and Abraxane® in Patients With Advanced Breast Cancer

CSPC Ouyi Pharmaceutical Co., Ltd.

Phase 1 Unknown
28 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡